These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2904577)

  • 1. Complement activation in plasma exchange.
    Lancet; 1988 Dec 24-31; 2(8626-8627):1464-5. PubMed ID: 2904577
    [No Abstract]   [Full Text] [Related]  

  • 2. Complement activation and endotoxin in sepsis.
    Padalino P; Gardinali M; Pallavicini J; Chiara O; Bisiani G; Nespoli A
    Prog Clin Biol Res; 1989; 308():277-82. PubMed ID: 2780700
    [No Abstract]   [Full Text] [Related]  

  • 3. Complement activation and vascular injury in systemic lupus erythematosus.
    Abramson S; Belmont HM; Hopkins P; Buyon J; Winchester R; Weissmann G
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():43-6. PubMed ID: 2886660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement activation and anaphylatoxin (C3a and C5a) formation in preeclampsia and by amniotic fluid.
    Haeger M; Bengtson A; Karlsson K; Heideman M
    Obstet Gynecol; 1989 Apr; 73(4):551-6. PubMed ID: 2784554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmental distribution of complement activation products in artificial kidneys.
    Cheung AK; Chenoweth DE; Otsuka D; Henderson LW
    Kidney Int; 1986 Jul; 30(1):74-80. PubMed ID: 3489123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement activation and clearance in acute illness and injury: evidence for C5a as a cell-directed mediator of the adult respiratory distress syndrome in man.
    Solomkin JS; Cotta LA; Satoh PS; Hurst JM; Nelson RD
    Surgery; 1985 Jun; 97(6):668-78. PubMed ID: 4002115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified cellulosic dialyzer membranes: an investigative tool in thrombogenicity studies.
    Mahiout A; Meinhold H; Kessel M; Vienken J; Baurmeister U
    ASAIO Trans; 1988; 34(3):878-81. PubMed ID: 3058187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement activation and the toxicity of stroma-free hemoglobin solutions in primates.
    Feola M; Simoni J; Dobke M; Canizaro PC
    Circ Shock; 1988 Aug; 25(4):275-90. PubMed ID: 3168173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass.
    Tennenberg SD; Bailey WW; Cotta LA; Brodt JK; Solomkin JS
    Surgery; 1986 Aug; 100(2):134-42. PubMed ID: 3738745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation and HLA-B27.
    Meri S; Partanen J; Leirisalo-Repo M; Repo H
    Ann Rheum Dis; 1988 Mar; 47(3):210-4. PubMed ID: 3258504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome.
    Langlois PF; Gawryl MS
    Am Rev Respir Dis; 1988 Aug; 138(2):368-75. PubMed ID: 3264125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of the terminal complement complex in patient plasma following acute myocardial infarction.
    Langlois PF; Gawryl MS
    Atherosclerosis; 1988 Mar; 70(1-2):95-105. PubMed ID: 3258520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunologic defense mechanism of complement-derived inflammatory chemical mediators].
    Yamamoto T; Kambara T
    Nihon Rinsho; 1988 Sep; 46(9):1974-80. PubMed ID: 3266512
    [No Abstract]   [Full Text] [Related]  

  • 14. Binding characteristics of the complement peptides C3a and C5a-desArg to cellulose nitrate filters in Boyden chambers.
    Damerau B; Wüstefeld H; Vogt W
    Agents Actions Suppl; 1983; 12():121-33. PubMed ID: 6601363
    [No Abstract]   [Full Text] [Related]  

  • 15. The significance of complement activation in the pathogenesis of hypersensitivity pneumonitis: sequential changes of complement components and chemotactic activities in bronchoalveolar lavage fluids.
    Yoshizawa Y; Nomura A; Ohdama S; Tanaka M; Morinari H; Hasegawa S
    Int Arch Allergy Appl Immunol; 1988; 87(4):417-23. PubMed ID: 2852642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation in type 1 human diabetes.
    Sundsmo JS; Papin RA; Wood L; Hirani S; Waldeck N; Buckingham B; Kershnar A; Ascher M; Charles MA
    Clin Immunol Immunopathol; 1985 May; 35(2):211-25. PubMed ID: 3907907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation in neonatal disease.
    Zilow EP
    Eur J Pediatr; 1993 May; 152(5):459-60. PubMed ID: 8319722
    [No Abstract]   [Full Text] [Related]  

  • 18. The phenomenon of leukergy: induction and detection of leukocyte aggregation in whole human blood.
    Berliner S; Fishelson Z; Bruhis S; Kaufman H; Pinhas J; Aronson M
    J Lab Clin Med; 1987 May; 109(5):575-82. PubMed ID: 3572206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement activation during blood donation.
    Morse AN; Churchill WH; Moore FD
    Transplant Proc; 1988 Dec; 20(6):1175-8. PubMed ID: 2974199
    [No Abstract]   [Full Text] [Related]  

  • 20. Complement activation and hypersensitivity reactions to dialysis membranes.
    Hakim RM; Breillatt J; Lazarus JM; Port FK
    N Engl J Med; 1984 Oct; 311(14):878-82. PubMed ID: 6332276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.